Bio-Techne Corporation
TECH
$54.41
$1.492.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -178.26% | -35.26% | 3.84% | -17.22% | -17.27% |
| Total Depreciation and Amortization | -161.26% | 1.80% | -3.74% | 251.74% | -167.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,847.77% | -66.10% | -14.40% | -30.42% | 419.99% |
| Change in Net Operating Assets | 272.71% | -202.41% | 225.24% | 4.87% | -869.05% |
| Cash from Operations | 138.82% | -51.25% | 32.02% | -15.37% | -6.78% |
| Capital Expenditure | 51.69% | -48.41% | 25.63% | 48.99% | -9.36% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 271.04% | -- | 100.00% | -236.42% | -- |
| Cash from Investing | 104.58% | -76.33% | 76.79% | -146.19% | 46.43% |
| Total Debt Issued | 73.68% | -- | -- | -- | -- |
| Total Debt Repaid | -525.00% | -- | 100.00% | 72.86% | -20.69% |
| Issuance of Common Stock | -58.14% | 168.45% | -77.93% | 9.45% | 25.11% |
| Repurchase of Common Stock | 0.05% | -30.92% | -1,437.74% | -1,139.80% | -139.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.53% | 1.22% | -0.38% | -0.48% | -0.38% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -32.93% | 18.84% | -624.54% | 80.75% | -14.65% |
| Foreign Exchange rate Adjustments | 1,335.99% | 80.23% | -206.90% | -3.18% | 325.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 158.34% | -269.12% | -127.95% | 201.02% | 21.39% |